Mangaluru, July 7: Srinivas College of Pharmacy, Mangaluru, in association with the IPA Local Branch, Mangaluru, organized an Industry–Institution Interaction Expert Lecture on “Challenges in Implementing the Revised Schedule M Guidelines” on 7 July 2026 at the college auditorium.
The programme was presided over by Dr. A. R. Shabaraya, Principal and Director, who emphasized the importance of industry–academia collaboration and encouraged students to enhance their practical knowledge alongside academic learning. Dr. Padma P. Prabhu welcomed the gathering and introduced the resource person.
The keynote address was delivered by Mr. Ramachandra Ganiga, Assistant Manager – Quality Assurance, Karnataka Antibiotics and Pharmaceuticals Limited (KAPL), Bengaluru, and an alumnus of Srinivas College of Pharmacy. He provided valuable insights into the revised Schedule M Good Manufacturing Practices (GMP) guidelines, highlighting the latest regulatory changes, implementation challenges, quality assurance systems, documentation practices, risk management, validation processes, and the importance of maintaining global quality standards in pharmaceutical manufacturing. Drawing from his industry experience, he also shared practical perspectives on regulatory compliance and career opportunities in pharmaceutical quality assurance.
The interactive session enabled students and faculty members to engage in discussions on GMP implementation and regulatory expectations. The programme was attended by Prof. Prakash V. Mallya, Coordinator, CPPA, Srinivas College of Pharmacy, and Dr. Kumar Prasad, Vice President, IPA Local Branch, Mangaluru, along with faculty members and students. Dr. Krishnananda Kamath, Professor and Head, Department of Pharmaceutics, proposed the vote of thanks, while the programme was compered by Ms. Apeksha and Ms. Amrutha, M.Pharm (Pharmacology) students.
The lecture concluded successfully, equipping participants with a deeper understanding of contemporary pharmaceutical manufacturing regulations and reinforcing the significance of quality systems in the pharmaceutical industry.
